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contribute to breast cancer risk assessment
in mammography screening: a case–control
study
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Michael Bachmann Nielsen1, Elsebeth Lynge2, Wei Yao Uldall1 and Ilse Vejborg1
Abstract
Background: Mammographic density is a well-established risk factor for breast cancer. We investigated the
association between three different methods of measuring density or parenchymal pattern/texture on digitized
film-based mammograms, and examined to what extent textural features independently and jointly with density
can improve the ability to identify screening women at increased risk of breast cancer.
Methods: The study included 121 cases and 259 age- and time matched controls based on a cohort of 14,736 women
with negative screening mammograms from a population-based screening programme in Denmark in 2007 (followed
until 31 December 2010). Mammograms were assessed using the Breast Imaging-Reporting and Data System (BI-RADS)
density classification, Tabár’s classification on parenchymal patterns and a fully automated texture quantification
technique. The individual and combined association with breast cancer was estimated using binary logistic regression to
calculate Odds Ratios (ORs) and the area under the receiver operating characteristic (ROC) curves (AUCs).
Results: Cases showed significantly higher BI-RADS and texture scores on average than controls (p < 0.001). All three
methods were individually able to segregate women into different risk groups showing significant ORs for BI-RADS D3
and D4 (OR: 2.37; 1.32–4.25 and 3.93; 1.88–8.20), Tabár’s PIII and PIV (OR: 3.23; 1.20–8.75 and 4.40; 2.31–8.38), and the
highest quartile of the texture score (3.04; 1.63–5.67). AUCs for BI-RADS, Tabár and the texture scores (continuous) were
0.63 (0.57–0–69), 0.65 (0.59–0–71) and 0.63 (0.57–0–69), respectively. Combining two or more methods increased model
fit in all combinations, demonstrating the highest AUC of 0.69 (0.63-0.74) when all three methods were combined (a
significant increase from standard BI-RADS alone).
Conclusion: Our findings suggest that the (relative) amount of fibroglandular tissue (density) and mammographic
structural features (texture/parenchymal pattern) jointly can improve risk segregation of screening women, using
information already available from normal screening routine, in respect to future personalized screening strategies.
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Background
Breast cancer remains the most common malignancy
among women worldwide, and is still the leading cause
of female cancer death in most European countries [1].
Mammography screening has proved to decrease breast
cancer mortality [2, 3]. Accordingly, breast cancer mortal-
ity was reduced by 25 % in screening targeted women
(37 % for women participating) in the first 10 years of the
Copenhagen Screening Programme [4]. Yet, two-view
mammography is not perfect due to limited sensitivity
and specificity particularly in women with dense breast
tissue [5–8]. Not only does increased breast density re-
duce mammographic sensitivity, but it has also been
firmly established as a strong risk factor for breast cancer.
It has been shown that women with high density (>75 %)
have a 4–6 times increased risk of breast cancer compared
with women with low density (<5 %) [7, 9]. Personalized
screening strategies based on a woman’s risk and mammo-
graphic sensitivity profile—including mammographic
density assessment—is much debated [10–13], and
informing screening-attendees of their BI-RADS density
has today been covered by legislation in more than 20 US
states, intending to improve screening for high-density-
women [14, 15].
Traditionally, mammographic density is measured semi-
quantitatively using the BI-RADS density classification [16]
or quantitatively as an area-based percentage of mammo-
graphic density with Cumulus-like techniques [17, 18].
However, numerous newer techniques are gaining ground
including fully automated volumetric measures (e.g.
Volpara and Quantra) [19–24] as well as methods for dens-
ity assessment using other modalities such as digital breast
tomosynthesis (DBT), MRI, photon counting spectral
mammography or ultrasound [25–27]. Still, the BI-RADS
density classification remains the only density method in
common clinical use. Currently, it is not fully understood if
the established association with breast cancer is contributed
by both the (relative) amount—density—but also the mam-
mographic structural appearance (texture/parenchymal pat-
tern). The Wolfe and Tabár classifications [28, 29] are
examples of more qualitative radiological methods. How-
ever, in recent years a range of new automated measures of
mammographic risk capturing textural/structural aspects of
mammographic density have been introduced [30–37],
which besides being associated with risk may improve risk
segregation using density parameters alone [30, 31, 34].
The objectives of this study were 1) to relate three
methods measuring density or corresponding structural
appearance on digitized film-based mammograms using
two well established radiological methods (the BI-RADS
density classification—semi-quantitative 4th editio-
n—and Tabar’s classification on parenchymal patterns)
and a new fully automated texture quantification tech-
nique (in this paper referred to as Mammographic
Texture Resemblance, MTR), and 2) to investigate to
what extent quantification of mammographic structural
appearance independently and jointly with density can
improve prediction of future breast cancer in screening
women, Fig. 1. We hypothesized that all three methods
can individually segregate women into different risk
groups, and that density and texture measurements on
negative screening mammograms can jointly improve
risk segregation.
Methods
Study population and mammograms
The design and population of this nested case–control
study, summarised in Fig. 2, have been described in detail
previously [38]. In brief, our study cohort consisted of all
14,736 women with a negative screening mammogram
(no cancer detected) in 2007—the last year with analogue
mammography—attending biennial routine breast screen-
ing in a population-based screening programme in
Copenhagen, Denmark. The women were followed until
31 December 2010. Information on death, emigration
and/or histologically verified breast cancer or ductal car-
cinoma in situ (DCIS) were retrieved and linked from the
following registers: the Danish Civil Registration System
(CRS), the Danish Cancer Registry, the Pathology Registry
and the Danish Breast Cancer Cooperative Group
(DBCG). In total, 132 women were diagnosed with inva-
sive breast cancer or DCIS. For each case, two controls
matched on year of birth were selected from the cohort
based on incidence density sampling [39]. Mammograms
Fig. 1 Density and texture as potential complementary mammographic
risk markers. It may be hypothesized that measures of the (relative)
amount of fibroglandular tissue and measures of the structural
appearance of the fibroglandular tissue (density and texture) may both
contribute to mammography detected risk. Increasing density and
increasing texture may independently add to the risk of breast cancer
(visualised as changes from the green colour zone to the light green/
light red colour zone). Low density + low texture indicate the lowest
mammographic risk (green colour) whereas high density + high texture
indicate the highest risk (red colour). Combining these two risk markers
could potentially improve risk segregation of screening women
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were not accessible for 16 women leaving 380 women for
the final analyses.
Use of screening data and tumour-related informa-
tion was approved by the Danish Data Inspection
Agency (2013–41–1604). This is an entirely register
based study and hence neither written consent nor
approval from an ethics committee was required
under Danish Law.
The craniocaudal (CC) and mediolateral oblique
(MLO) projections from each breast were digitized
using a Vidar Diagnostic PRO Advantage scanner
(Vidar systems corporation, Herdon, VA, USA) pro-
viding an 8-bit (256 grey scales) output at a reso-
lution of 75–150 DPI. These images were assessed
radiologically. However, a higher resolution is re-
quired for fully automated computerized techniques.
Thus, to assess the automated MTR scores, mammo-
grams were re-scanned on an equivalent Vidar Diag-
nostic PRO Advantage scanner providing a 12-bit
(4096 grey scales) output at a resolution of 570 DPI
with upgraded software (eFilm Scan 2.0.1 Build 586).
At rescanning images from four women could not be
recovered and were excluded from the present study
(Fig. 2).
Mammographic classification
The digitized mammograms were classified according to
two radiological methods: The 4th edition of the Ameri-
can College of Radiology (ACR)’s Breast Imaging-
Reporting and Data System (BI-RADS) density classifica-
tion [40] and the Tabár classification on parenchymal
patterns [29, 41]. Both classification schemes were de-
tailed in Winkel et al. (2015) [38]. In brief, the BI-RADS
density classification assigns mammograms semi-
quantitatively into four categories: D1: fatty (<25 %
fibro-glandular tissue), D2: scattered fibro-glandular
densities (25–50 %), D3: heterogeneously dense (51–
75 %) and D4: extremely dense (>75 %) [40]. The Tabár
classification is based on a histological-mammographic
correlation and mammograms are assigned into five
more descriptive/qualitative categories: PI: Scalloped
contours with oval-shaped lucencies and evenly scat-
tered 1–2 mm nodular densities, PII: Almost complete
fatty replacement, PIII: Like PII with a retroareolar
prominent duct pattern (representing periductal con-
nective tissue proliferation or distended fluid-filled
ducts), PIV: Prominent nodular and linear densities with
nodular densities larger than normal lobules (represent-
ing a variety of changes i.e. adenosis or fibrosis) and PV:
Fig. 2 Flowchart of study design and population
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Dominated by homogeneous, ground glass like and
nearly structure-less densities (representing extensive fi-
brosis) [29, 41]. Two MDs—a senior breast radiologist
(5 years full-time experience in breast radiology) and a
resident in radiology (no previous experience in breast
radiology)—independently classified the randomized
mammograms according to the two radiological
methods. More precise density measures are achieved
when mentally fusing two projections compared with
assessing only a single projection of the breast. There-
fore, CC and MLO views were evaluated together equal
to clinical practise. Evaluation by the Tabár classification
was done blinded from the BI-RADS assessment (sepa-
rated in time) in order to reduce artificial agreement
between the two methods. The readers were also blinded
to the original mammographic reading, the date of
examination, the woman’s age and case/control-status.
Inter-observer reproducibility on the two manual
methods (based on each breast) was substantial demon-
strating kappa values of 0.68 (0.64–0.72) and 0.64 (0.60–
0.69) for BI-RADS and Tabár, respectively [38]. For stat-
istical analyses, consensus scores were obtained if the
two readers disagreed.
Subsequently, all mammograms were assessed by a
fully automated mammographic texture resemblance
marker (denoted MTR) [42]. The MTR scores were cal-
culated using a deep learning convolutional neural net-
work pipeline by Biomediq [42]. Initially, a number of
mammogram specific texture building blocks were
trained in an unsupervised manor (using no cancer label
information) from a large collection of mammograms.
Then, we used patches from a database of diagnosis-free
mammograms with known cancer outcome to train the
MTR pipeline to assign a posterior probability of cancer
risk to individual patches extracted from a mammogram.
The MTR pipeline used in the present study was trained
on data from three different independent populations.
The first two were used in earlier texture studies [30, 31]
and the third consisted of a case/control study similar to
the current one, but using 2006 data and including 93
cases and 86 controls. The aggregate risk of a new mam-
mogram is the average MTR posterior across extracted
patches – typically 500 patches/scores per mammogram.
The technical details can be found in [42]. An average of
the CC and MLO projection was used to denote the au-
tomated MTR breast score. For the 4 women with only
MLO images available, CC measures were estimated
using linear regression.
In order to assign a single final score per woman for
each method, the highest risk score was used if the two
breasts differed. This approach is also normal procedure
in the Copenhagen routine mammography screening
programme, just as it is stipulated by ACR [14]. Funda-
mentally, the Tabár classification is not categorised
according to a continuous risk scale. Based on risk
evaluation available from the literature we ranked the
Tabár classification as follows: PII, PIII, PI, PV, PIV
where the low-risk patterns PI-PIII were ranked based
on increasing density [29, 41, 43].
Statistical analysis
Group characteristics for cases versus controls
Mean and 95 % CI were calculated for cases and con-
trols separately regarding BI-RADS, MTR and age at
screen, and group characteristics were compared using
linear mixed model for analysis of matched pairs.
Association between methods
Median and inter-quartile range of MTR for each of the
four BI-RADS and five Tabár categories as well as their
combined subgroups were calculated. The pair-wise rela-
tions between methods were also demonstrated graphic-
ally using bar charts and box-and-whisker plots. The
correlation between BI-RADS and Tabár was evaluated
using Fisher’s exact test and Cramer’s V, and the correl-
ation between MTR scores and the ordinal BI-RADS
classification was evaluated using Spearman’s rho. Differ-
ences in MTR scores for each BI-RADS or Tabár cat-
egory after stratification on case–control status were
evaluated using linear mixed models for analysis of
matched pairs (including age at screen as a co-variant).
Association with breast cancer
The ability of each individual method to separate cases
from controls were evaluated using 1) logistic regression
to calculate Odds Ratios (ORs) and 2) area under the re-
ceiver operating characteristic curves (AUCs). To calcu-
late ORs similar to the two categorical classifications,
the continuous MTR measure was categorised using
cut-offs from the quartiles of control subjects. For all
methods, each density/texture group was compared indi-
vidually with the most fatty breast or lowest quartile
(reference): D1 for BI-RADS, PII for Tabár, and the low-
est quartile for MTR. We intended to base this study on
information always available at screening—the woman’s
age and her mammogram. Thus, only age at screening
was adjusted for in the multivariate analysis, as informa-
tion on body mass index (BMI) and other known risk
factors for breast cancer are not collected routinely.
Moreover, we investigated the potential gain in predic-
tion of breast cancer when using information from mul-
tiple methods in conjecture. To do so we used multiple
logistic regression models, including main effects of vari-
ous selections of predictors (age at screen, BI-RADS,
Tabár and MTR). No interaction terms were found to be
significant and these were therefore not included in the
models. For each suggested model we computed AUCs
based on its estimated linear predictor, and ORs for the
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model were reported by categorizing the linear predictor
according to the quartiles of the controls. The statistical
significance of differences between AUCs were assessed
using the DeLong test [44].
IBM SPSS Statistics 20, Copyright © IBM Corporation
1989–2011, was used for statistical analysis and results
were considered statistically significant with two-sided
P-values < 0.05.
Results
Table 1 shows the characteristics of cases and controls.
Only a very small age difference (however significant)
was seen between cases and controls (mean age of 57.9;
57.0–58.8 versus 58.2; 57.5–58.9, respectively) consistent
with the age matched design on year of birth. From the
121 included cases 91 % were diagnosed with invasive
breast cancer and the remaining with ductal carcinoma
in situ (DCIS). Time from screening to diagnosis was 4
to 45 months with an average of 26 months. On average,
cases demonstrated significantly higher BI-RADS density
and automated texture scores than controls.
Table 2 summarizes the categorization of women into
BI-RADS and Tabár patterns in a cross tabulation with
corresponding median measures and inter-quartile
ranges according to the automated texture scores. The
pair-wise relations between the different methods are
shown in Fig. 3. The BI-RADS and Tabár classifications
were associated (p < 0.001) with Cramer’s V of 0.60 indi-
cating a moderate association (Fig. 3a + b). Thus, women
categorized into Tabár’s fatty PII and PIII were only seen
in the two low-density BI-RADS categories (D1 + D2).
Likewise, Tabár’s PIV and PV were mainly seen in the
two high-density BI-RADS categories (D3 + D4). How-
ever, 23 women (6 %) with low density (D2) according to
BI-RADS were classified with a high-risk nodular Tabár
PIV. Tabár’s PI were distributed into all four BI-RADS
categories but concentrated in the two middle categories
– primarily D2. As demonstrated in Fig. 3c the auto-
mated texture scores increased with increasing BI-RADS
density, however, with a drop in MTR scores as regards
the extremely dense breasts (Spearman’s rho = 0.27;
0.17-0.37). A similar pattern was seen when the MTR
scores were related to the five Tabár categories (Fig. 3d).
The lowest texture scores were observed for the fatty PII
and PIII breasts and increased for PI and even more for
PIV, which demonstrated the highest MTR scores. A
pronounced decrease in texture was seen for PV. When
stratified into cases and controls, we saw a tendency for
cases to reveal higher texture scores than controls in the
three least dense BI-RADS categories (D1-D3) and the
following Tabár categories: PI, PII and PIII (significant
for category D1, D3 and PI).
Table 3 demonstrates how all three methods were able
to segregate women into different risk groups. We found
that the risk of breast cancer in terms of ORs adjusted
for age were significantly higher for women with BI-
RADS D3 and D4 (OR 2.37; 1.32–4.25 and 3.93; 1.88–
8.20), Tabár’s PIII and PIV (OR 3.23; 1.20–8.75 and 4.40;
2.31–8.38) and the upper quartile (Q4) of the MTR
score (3.04; 1.63–5.67). To enable comparison between
the different methods, independent of reference cat-
egory, AUCs were also calculated for each method. Age
adjusted AUCs for BI-RADS, Tabár and MTR were 0.63
(0.57–0.69), 0.65 (0.59–0.71) and 0.63 (0.57–0.69) (con-
tinuous), respectively.
The baseline AUC of 0.63 for BI-RADS density in-
creased to 0.66–0.67 (non-significantly) when combining
BI-RADS with either of the two other measures (Tabár
or MTR). Combining all three measures increased AUC
slightly more to 0.69 (0.63–0.74), which was significantly
different from BI-RADS and texture alone. ORs based
on the categorized new linear predictors from the com-
bination models are also shown in Table 3.
Discussion
Screening for breast cancer is entering an era of person-
alized screening. Hence, mammography screening is
moving from the “one-size-fits-all” towards tailored
screening strategies based on a woman’s risk profile (in-
cluding density) [10, 12]. In Denmark—as in many other
countries—population-based breast cancer screening is
today based solely on the age of the woman. The only
exception is intensified screening for the small subset of
women belonging to families with moderately/highly in-
creased lifetime risk (>30 %) or high-susceptibility genes
as BRCA1 and BRCA2. In a previous study we investi-
gated inter-observer agreement regarding three subject-
ive methods for density assessment [38]. In that study
we addressed the current concerns about reproducibility
if subjective methods are used to separate screening
women. In the current study (based on the same case/
control population) we focused on whether different
methods may complement each other in risk assessment
of screening women. Accordingly, we addressed whether
it is relevant to distinguish between the (relative)
amount of mammographic fibroglandular tissue
(density)—BI-RADS scores—and the mammographic
Table 1 Group characteristics for cases versus controls
Casesa (n = 121) Controls (n = 259)
Mean 95 % Cl Mean 95 % Cl P-valueb
Age 57.9 57.0–58.8 58.2 57.5–58.9 0.016
BI-RADS 2.44 2.24–2.64 1.98 1.86–2.10 <0.001
MTR 0.541 0.535–0.547 0.526 0.522–0.530 <0.001
Highest score of left or right breast for BI-RADS and MTR (MTR breast score:
average of CC and MLO)
aDCIS 9.1 % and invasive cancer 90.9 %
bStatistics: Linear mixed model for matched pairs
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structural appearance (parenchymal pattern/texture)—-
Tabár and MTR scores—when determining the risk of
future breast cancer. We found that all three methods
were significantly associated with the risk of breast can-
cer. Furthermore, we demonstrated a significant im-
provement of the risk model when all three methods
were combined into one aggregate measure of mammo-
graphic risk compared with density or texture alone.
Even though, only a seemingly modest increase in dis-
criminatory power was seen from an AUC of 0.63 for
BI-RADS alone, to 0.66-0.67 when combining BI-RADS
with either of the two other measures, and to 0.69 when
combining all three measures, the AUCs must be
regarded in the light of population-based screening.
Even small improvements may have an impact at the
population level, which was also demonstrated by the in-
creasing gradient in breast cancer risk for the combin-
ation models seen in Table 3. Several studies have
similarly found that adding new risk factors to already
existing risk models only tends to show a modest in-
crease in the discriminatory power [11, 45–48]. How-
ever, this remains of importance in outlining high-risk
groups on a population basis [49]. Our results indicated
that the three measures most likely captured different
aspects of breast cancer risk, suggesting that a combined
measure of density and structural appearance may well
improve mammographic risk assessment in a future per-
sonalized population-based screening setting.
Overall, ORs were comparable with previous studies
using identical density measures. The association be-
tween breast density and breast cancer risk as well as
screening sensitivity has been well established in
numerous previous studies [9, 50, 51]. In a prospective
study, including more than 60,000 women followed for
an average of 3.1 years, Vacek and Geller (2004) reported
age-adjusted relative risks based on the BI-RADS density
classification (D4 vs. D1) of 4.61 for premenopausal
women and 3.88 for postmenopausal women [52]. Cor-
respondingly, in a prospective cohort of 1 million
women, Barlow and colleagues (2006) reported ORs of
3.93 and 3.15, respectively [11]. This is consistent with
our OR of 3.93 for D4 versus D1 in predominantly post-
menopausal women.
Few studies have investigated breast cancer risk apply-
ing the Tabár classification. Jakes et al. (2000) found
unadjusted ORs of 2.30 (1.14–4.63) for PIV and 1.63
(0.72–3.68) for PIII using PI instead of the fattiest breast
(PII) as a reference [43], which is well in accordance
with our results giving ORs of 2.43 (1.41–4.18) for PIV
and 1.78 (0.70–4.57) for PIII when PI is used for com-
parison. They demonstrated consistent ORs for the
nodular PIV when individually adjusting for other risk
factors. In addition, Jakes et al. did not observe any in-
creased risk for PV (OR 0.78; 0.40–2.08), just as we did
not find this pattern to be associated with increased risk
of breast cancer (OR 1.09 (0.41–2.87) for PV versus PI).
Finally, risk segregation using the automated texture
quantification technique was comparable with previous
findings using earlier versions of the software [30, 31].
Based on a Dutch population, age-adjusted ORs for Q4
versus Q1 was 3.4 (2.1–5.8) (using cross-validation) and
MTR scores were found to be independent of area per-
centage density [30]. This was supported by a subse-
quent study yielding an OR of 2.2 (1.4-3.6) for Q4 versus
Table 2 Distribution of BI-RADS and Tabár patterns with corresponding median measures of MTR in 380 women
BI-RADS
Total: D1 D2 D3 D4
380 (0.32) 137 (0.22) 104 (0.30) 94 (0.39) 45 (0.51)
0.532 (0.508–0.554) 0.522 (0.496–0.537) 0.534 (0.515–0.561) 0.549 (0.523–0.567) 0.532 (0.494–0.564)
Tabár
I 134 (0.28) 20 (0.35) 75 (0.25) 37 (0.28) 2 (0.50)
0.538 (0.520–0.558) 0.538 (0.528–0.557) 0.535 (0.511–0.560) 0.540 (0.520–0.555) 0.528 (0.511–0.545)a
II 101 (0.18) 100 (0.17) 1 (1.00) 0 0
0.520 (0.493–0.536) 0.519 (0.493–0.535) 0.562 (−) - -
III 22 (0.41) 17 (0.35) 5 (0.60) 0 0
0.506 (0.494–0.524) 0.500 (0.491–0.524) 0.513 (0.496–0.541) - -
IV 100 (0.49) 0 23 (0.35) 48 (0.52) 29 (0.55)
0.552 (0.529–0.572) - 0.535 (0.527–0.565) 0.556 (0.544–0.577) 0.547 (0.497–0.570)
V 23 (0.30) 0 0 9 (0.11) 14 (0.43)
0.517 (0.478–0.535) - - 0.509 (0.452–0.537) 0.521 (0.479–0.537)
The proportion of cases is displayed in brackets next to the number of women in each cell
The median and inter-quartile range is shown in italics for the MTR score
a The two values in this cell are shown in brackets instead of the inter-quartile range
Winkel et al. BMC Cancer  (2016) 16:414 Page 6 of 12
Q1 (when adjusted for BMI, age at menopause and post-
menopausal hormone use). This study demonstrated
that MTR generalizes as an independent risk factor (tex-
ture was estimated using training data from another co-
hort) [31]. The comparable ORs with previous findings
are indicative of a general applicability of all three
methods.
The underlying biological linkage between mammo-
graphic density (or density features) and breast cancer
risk remains largely unresolved. Overall, a mammo-
gram can be dominated by 1) fat 2) nodular/linear
densities in varying amounts with potential biological
(proliferative) activity and 3) homogeneous fibrous
densities. In our study, the three methods largely
agreed on the fatty breasts. Thus, BI-RADS D1 con-
sisted mainly of fat involved PII and PIII breasts
(Fig. 3a) and, in accordance; these predominantly
structureless categories all revealed low texture scores
(Fig. 3c and d). However, regarding mammograms
with increasing density (mammograms with more
structure, BI-RADS D2-D4) it was seen that they
changed from being dominated by the “normal” Tabár
PI pattern (in D2) to comprising the homogeneous
dense PV pattern on behalf of PI (in D4). Moreover,
the relative proportion of PIV patterns increased with
increasing density (Fig. 3a). Thus, the more fibro-
glandular tissue on a mammogram the greater the
risk of being categorized with a more aggressive look-
ing PIV (or otherwise categorized as PV dominated
by fibrosis which may or may not be associated with
underlying proliferative activity). Taking the MTR
scores into account it was illustrated how texture in-
creases with increasing BI-RADS density but then de-
creases again for the extremely dense breasts (D4)
Fig. 3 Pair-wise relation between three methods of assessing mammographic density or structural appearance (n = 380). a The proportional
distribution of Tabár patterns within each BI-RADS category. b Mean BI-RADS score for each Tabár category. c Box-and-whisker plot showing the
median (horizontal line), interquartile range (the box) and top + bottom 25 % of the scores except from outliers (whiskers) for the Mammographic
Texture Resemblance scores for each BI-RADS category. d Box-and-whisker plot showing the MTR distribution for each Tabár category. *Significant
difference between cases and controls
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(Fig. 3b). This can be due to D4 consisting of rela-
tively more PV patterns with less structural features.
The moderately dense breasts (D2 + D3) consist pri-
marily of PI and PIV categories with the largest rela-
tive proportion of PIV in D3 breasts. The increase in
texture scores from D2 to D3 and the fact that PIV
reveals the highest texture scores suggests that MTR
can distinguish breasts with a more aggressive
pattern (PIV) from breasts with a less aggressive pat-
tern (PI).
Table 3 Association between mammographic density/structural appearance and breast cancer in 380 screening womena
Cases/controls (n) Case-ratio OR (95 % Cl)b p-value AUC (95 % Cl)b
BI-RADS 0.63 (0.57–0.69)
D1 30/107 21.9 1 (reference) -
D2 31/73 29.8 1.53 (0.85–2.75) NS
D3 37/57 39.4 2.37 (1.32–4.25) 0.004
D4 23/22 51.1 3.93 (1.88–8.20) <0.001
Tabár 0.65 (0.59–0.71)
PI 38/96 28.4 1.81 (0.96–3.42) NS
PII 18/83 17.8 1 (reference) -
PIII 9/13 40.9 3.23 (1.20–8.75) 0.021
PIV 49/51 49.0 4.40 (2.31–8.38) <0.001
PV 7/16 30.4 1.97 (0.70–5.57) NS
Automated texture (MTR)c 0.63 (0.57–0.69) cont.
0.63 (0.56–0.69) cat.
Q1 19/65 22.6 1 (reference) -
Q2 24/65 27.0 1.27 (0.63–2.54) NS
Q3 21/65 24.4 1.11 (0.54–2.25) NS
Q4 57/64 47.1 3.04 (1.63–5.67) <0.001
BI-RADS + MTR 0.66 (0.60–0.72)
Q1 11/64 14.7 1 (reference) -
Q2 23/65 26.1 2.06 (0.93–4.57) NS
Q3 33/66 33.3 2.91 (1.36–6.25) 0.006
Q4 54/64 45.8 4.91 (2.35–10.24) <0.001
BI-RADS + Tabár 0.67 (0.61–0.72)
Q1 13/64 16.9 1 (reference) -
Q2 19/64 22.9 1.46 (0.67–3.21) NS
Q3 30/66 31.3 2.24 (1.07–4.67) 0.032
Q4 59/65 47.6 4.47 (2.24–8.94) <0.001
Tabár + MTR 0.68 (0.62–0.73)
Q1 13/65 16.7 1 (reference) -
Q2 22/65 25.3 1.69 (0.79–3.64) NS
Q3 24/65 27.0 1.85 (0.87–3.94) NS
Q4 62/64 49.2 4.84 (2.43–9.66) <0.001
BI-RADS + MTR + Tabár 0.69 (0.63–0.74)
Q1 12/64 15.8 1 (reference) -
Q2 16/66 19.5 1.29 (0.57–2.95) NS
Q3 28/65 30.1 2.30 (1.08–4.91) 0.032
Q4 65/64 50.4 5.42 (2.67–10.98) <0.001
aBI-RADS and Tabár are based on consensus scores between two readers. Regarding all three methods the maximum breast score has been used as the woman’s
final score (Tabár ranked as follows: PII, PIII, PI, PV, PIV). Regarding MTR an average of CC and MLO was used as the breast score
bORs and AUCs are adjusted for age. A significant difference in AUC was seen for BI-RADS + Tabár + MTR versus BI-RADS and BI-RADS + Tabár +MTR versus MTR
cCut points for MTR scores are based on an equal number of controls in each group: Q1) 0–0.5047, Q2) 0.5047-0.5284, Q3) 0.5284-0.5469, Q4) 0.5469-1.00
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In general, we saw increasing ORs with increasing BI-
RADS density (significant for D3 +D4) and correspond-
ingly for Tabár PII- > PI- > PIV (significant for PIV).
Similarly, MTR Q4 scores were significantly associated with
increased risk. For all methods the fattiest (most structure-
less) breasts—which are also the easiest to read radiologi-
cally—were associated with lowest risk. The enlarged
nodular and linear densities characteristic of Tabár’s PIV
has been associated with a variety of benign changes of the
breast parenchyma [41], and an inverse association with
parity has been demonstrated [43, 53]. Interestingly, no sig-
nificantly increased risk for Tabar PV was captured. This
can be explained by the relatively few women categorized
with this pattern (6 %), but might also be due to the struc-
tureless appearance. In addition, it could be attributed to
misclassification into PV instead of PI. We also demon-
strated increased ORs for Tabár’s PIII (supported by equiva-
lent findings by Jakes et al., 2000). PIII is a fat involved
breast, but is occupied by a retroareolar prominent duct
pattern which—similar to PIV—has a more “aggressive”
radiological appearance. However, MTR scores were not in-
creased in regards to this specific pattern, presumably be-
cause this technique is based on average measures from
numerous patches throughout the entire breast. In general,
cases showed higher MTR scores than controls regarding
all low-density patterns (BIRADS D1-D3 and Tabár PI-PIII)
and 28 cases were identified in low density breasts. This in-
dicates that the MTR technique captures a mammographic
detectable risk that is different from risk due to density
alone (Fig. 1). Thus, different features of breast morphology
(amount, composition and organization of breast tissue) ap-
pear to be retrieved by the three various methods capturing
different elements of risk. We didn’t observe any difference
in cancers identified by the three methods according to
DCIS/invasive-status.
In tailored screening, masking plays a significant role.
Accordingly, women with high density might benefit
from supplementary imaging with e.g. ultrasound, tomo-
synthesis, MRI or altered screening intervals. The fifth
edition of BI-RADS no longer indicates quartiles of per-
centage dense tissue [14]. This has been done to put an
emphasis on the masking potential of different density
patterns as opposed to percentage breast density being
an indicator for breast cancer risk. Tabár has also
emphasised the masking potential for pattern IV and V
rather than a biological risk [41]. However, data from
the Swedish Kopparberg randomized controlled trial
showed a RR of 1.57 (1.23–2.01) for dense (PIV and PV)
versus non-dense (PI, PII and PIII) mammograms after
25 years of follow-up, and a recent study found the asso-
ciation between mammographic density and breast can-
cer risk to persist up to 10 years after the baseline
mammogram [8, 54]. Thus, the increased risk from base-
line breast density patterns seems to remain after long-
time follow-up indicative of an inherent risk which can-
not be explained by the masking effect. In our study the
BI-RADS D4 category showed the greatest masking po-
tential of all groups. Thus, 39 % of the cancers in this
category were diagnosed before the woman’s next regu-
lar screen (<2 years from baseline screen); an even
higher proportion were seen for the combined D4/PIV
subgroup (44 % - data not shown). Correspondingly, we
saw that effect sizes increased quite notably, especially
when using the BI-RADS and Tabár classification, when
only looking at cancers diagnosed < 2 years from the
baseline screening (Additional file 1). This suggests that
certain BI-RADS and Tabár patterns, in particular, are
strongly indicative of the potential of masking. However,
all three methods were still able to stratify women into
the risk of future breast cancer (cancers diagnosed
≥2 years from baseline; Additional file 1).
Limitations
Our study has some limitations. First of all, the sample
size of included women is rather small leading to wide
confidence intervals and restricting stratification into
subgroups. Next, two subjective methods were investi-
gated introducing uncertainty about reproducibility.
However, we used consensus scores from two independ-
ent readers which had demonstrated substantial inter-
observer agreement for both methods [38]. Both readers
had no previous experience using the Tabár classification
and only one of the readers had experience from clinical
mammography (not screening) regarding the BI-RADS
classification. The lack of experience only adds to ro-
bustness of the classifications and the ORs found in this
study. We also have a relatively short follow-up period
of 3–4 years. A small study by van Gils et al. (1998)
found the effect of masking to be small but to peak 3–4
years after the initial screening [55]. In addition, we did
not control for any other risk factors or confounders
(except from age) in this retrospective study which
might have influenced our risk estimates. In particular,
BMI has been reported an important confounder espe-
cially among postmenopausal women, and adjusting for
BMI would expectably have led to some increase in OR
estimates [51, 52, 56]. However, the lack of further ad-
justments is equal for all the methods being compared.
Besides, we intended to base our study exclusively on
data available at screening. From a clinical point of view,
our results are more directly applicable in present
screening programs where the mammogram in addition
to the woman’s age is the only available information to
the radiologist.
Conclusions
This study confirms the increased risk of breast cancer as-
sociated with high mammographic density (BI-RADS D3
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and D4), Tabár’s PIV and high measurements of mammo-
graphic texture. Furthermore, it provides more evidence
that mammographic structural features and density can be
considered independent biomarkers for breast cancer risk.
Both Tabár and MTR identify women at increased risk of
breast cancer who have low density, and our study sug-
gests that breast cancer risk may be attributable to differ-
ent mammographic features captured by each of the three
methods. However, it might not be feasible to introduce
more classifications for radiologists to adapt and apply in a
busy and comprehensive screening environment. A combi-
ned—and optimally automated—measure of density and
texture could form the basis of a future prospective valid-
ation study, which evaluates the impact of risk based strati-
fication on breast cancer diagnosis, false positive rate, and
breast cancer mortality. This could be moving closer to an
applicable mammographic risk marker in population-based
screening, in respect to a potential future individualized
screening set-up.
Additional file
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